Stock Analysis

Insider Returns Down To US$374k As InspireMD's Stock Dips 11%

NasdaqCM:NSPR
Source: Shutterstock

Insiders who bought InspireMD, Inc. (NASDAQ:NSPR) in the last 12 months may probably not pay attention to the stock's recent 11% drop. After taking the recent loss into consideration, the US$400k worth of stock they bought is now worth US$774k, indicating that their investment yielded a positive return.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Check out our latest analysis for InspireMD

The Last 12 Months Of Insider Transactions At InspireMD

The Independent Director Michael Berman made the biggest insider purchase in the last 12 months. That single transaction was for US$200k worth of shares at a price of US$1.63 each. Even though the purchase was made at a significantly lower price than the recent price (US$3.16), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

InspireMD insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
NasdaqCM:NSPR Insider Trading Volume September 21st 2023

InspireMD is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership Of InspireMD

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that InspireMD insiders own 17% of the company, worth about US$11m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The InspireMD Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. However, our analysis of transactions over the last year is heartening. Insiders do have a stake in InspireMD and their transactions don't cause us concern. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing InspireMD. Be aware that InspireMD is showing 5 warning signs in our investment analysis, and 3 of those are significant...

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqCM:NSPR

InspireMD

A medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.

Flawless balance sheet low.